ABSTRACT
review methODs
The study included 30 drug names that are commonly misspelt on prescription charts in hospitals in Birmingham, UK (test set), and 30 control names randomly chosen from a hospital formulary (control set). The following definitions were used: standard names-the international non-proprietary names, variant names-deviations in spelling from standard names that are not themselves standard names in English language nomenclature, and hidden reference variants-variant spellings that identified publications in textword (tw) searches of PubMed or other databases, and which were not identified by textword searches for the standard names. Variant names were generated from standard names by applying letter substitutions, omissions, additions, transpositions, duplications, deduplications, and combinations of these. Searches were carried out in PubMed (30 June 2016) for "standard name [tw] " and "variant name [tw] NOT standard name [tw] ." results The 30 standard names of drugs in the test set gave 325 979 hits in total, and 160 hidden reference variants gave 3872 hits (1.17%). The standard names of the control set gave 470 064 hits, and 79 hidden reference variants gave 766 hits (0.16%). Letter substitutions (particularly i to y and vice versa) and omissions
Introduction
Variant spellings of drug names can cause confusion, which could lead to serious harm. 1 2 Nevertheless, these names are expected to be correctly spelled and indexed in published work. We have tested this assumption, which underlies many search strategies for systematic reviews and meta-analyses of therapeutic interventions.
Methods
We defined the following types of drug names:
• Standard name: the international non-proprietary name (INN) 3 or (if there was no INN) the British Approved Name (BAN; box 1).
• Variant name: any deviation in spelling from the standard name that was not itself a standard name in English language nomenclatures, such as BANs or US Adopted Names (USANs). For example, we did not regard thimerosal (USAN) as a transpositional variant of thiomersal (INN), although many papers would be missed by not searching for both.
• Hidden reference variant: a variant spelling that, when used as a textword search term in PubMed and other databases, identified publications that were not identified by searching for the standard name as a textword.
Senior pharmacists from hospitals in Birmingham, UK provided 30 examples of drug names that were commonly misspelt on hospital prescription charts. We then chose a control set of 30 drugs at random from the Sandwell and West Birmingham Hospitals NHS Trust formulary. We ran a search in PubMed 4 on 30 June 2016 for textword instances of the standard name of each drug and for spelling variants created by the following types of changes:
• Substitutions (eg, i to y and vice versa; one unaccented vowel to another vowel or y; soft c to s and vice versa; hard c to k and vice versa; ch to k; f to ph
WhAT IS AlReAdy knoWn on ThIS TopIC
Spelling errors are not uncommon in databases such as PubMed and Medline Drug names are frequently misspelt in these databases and in hospital prescription charts
WhAT ThIS STudy AddS
Database searches using only drug names spelt correctly will miss relevant references in which the names are spelt incorrectly These references, which include systematic reviews, will remain hidden unless searches are also undertaken using possible misspellings types of variant Table 3 shows frequencies of the different types of spelling variants. *Included one case of the variant "amitiptyline" lacking the r, and one of "amitriptyine" lacking the l. There was no variant in which the final i was replaced by a y. †Amitriptyline, the standard name, gave 8530 hits.
We examined names ending in "micin" in detail. Most of the errors occurred with the standard form "gentamicin" compared with the variant "gentamycin," which resulted in 21 384 and 1977 hits (9.25%), respectively. The ending "mycin" was also often substituted in fidoxamicin (2.02%) and netilmicin (2.46%; table 4 ). In contrast, in 19 standard drug names ending in "mycin" (218 415 hits), the hidden reference variant "micin" was rare (157 hits (0.07%); table 5).
Names ending in "in" or "ine" were also likely to generate hidden spelling variants by addition or omission of the final "e." The 28 standard names of this type in the test and control sets combined yielded 296 973 hits and hidden spelling variants yielded 3450 hits (1.16%), compared with 499 070 hits and 1188 hits (0.24%), respectively, for the other 32 names.
searches for systematic reviews We found 87 systematic reviews or meta-analyses that mentioned the standard name gentamicin, 0.41% of all hits for "gentamicin [tw] ." We found six further systematic reviews (6.5% of the total) in PubMed after searching for hidden reference variants of gentamicin. In Medline, the equivalent search for "gentamicin.af."
(where af=all fields) identified 141 systematic reviews, with 19 782 hits (0.71%). The hidden reference variants, with 863 hits, identified 15 additional systematic reviews (9.6% of the total).
Similarly, for amitriptyline, we found 179 systematic reviews in PubMed and another five as hidden reference variants. Corresponding numbers were 110 and six for mirtazapine and 47 and two for trazodone. Thus, for these drugs, 19 systematic reviews of 455 (4.
• Standard names ending in "micin" (no=1, yes=2).
The product of these factors, a variant index score, was on average much higher in the test group (range 54-4480; median 524) than the control group (range 36-1440; median 272).
discussion
We have uncovered a potential indirect harm from incorrect variant spellings of drug names that has not previously been investigated, to our knowledge, although others have reported misspelt general medical textwords in Medline 8 and misspellings of the word "random" and its derivatives in Medline and EMBASE. 9 Difficulties in recognising and distinguishing drug names can lead to clinical harm directly, for example, when one drug name is read as another. Here, we demonstrate the extent to which medical literature searches can be frustrated by textword searches that fail to include variant spellings, since articles referenced only by the variant spelling will remain hidden. PubMed offers the correct spelling (eg, gentamicin) when you enter an incorrect one (eg, gentamycin), but not the other way round-searching for "gentamicin[tw]" does not yield incorrect spellings.
Information in systematic reviews can be lost if the review is indexed under a hidden reference variant and not under the textword for the standard name. The problem is not limited to PubMed. In Medline, 13 systematic reviews were hidden under the variant spelling "gentamycin." In the Cochrane Database of Systematic Reviews, 5 there were 15 systematic reviews of "gentamicin," but use of the term "gentamycin" identified four otherwise hidden reviews.
The most obvious way to mitigate this problem is for authors and editors to take care over the correct spellings of drug names. Indexing could be improved, especially by ensuring that standard names are always used Another solution is to use wild cards, if available. Medline allows users to search for words that are spelt with alternative letters. For example, a search for "amitriptyline.af." yields 8092 hits. Searching for "am#tr#pt#line.af." uncovers all variant spellings with i to y substitutions (and vice versa) in amitriptyline (table 2), revealing 123 hidden reference variants. The textword "am#tr#pt#l*.af." truncated at the letter l uncovers variants of the last few letters (for example, ending in "lin," "line," "llin," "lline") without sacrificing specificity, and gives further hits. However, this does not exhaust all variant forms. For example, the hidden reference variant amitiptyline, generated by omission, was missed.
The variant index score that we have calculated from eight important features associated with hidden reference variants affords insight into the likelihood that newly coined names might prove problematic. Combining the index score with Trigram-2b or the Levenshtein distance, which measure how likely names are to be confused, 6 7 could help reduce problems with new names.
It has been suggested that all relevant spelling variants should be included in search strategies. However, this recommendation did not refer to incorrectly spelt variants as opposed to variants in standard spelling, such as those between US and UK English (eg, anemia and anaemia), and did not mention drug names. 10 limitations Although we systematically generated variants of standard names of drugs (as described in the methods), we could have missed some variants, and underestimated the frequencies of hidden reference variants. In the Xmas spirit, we offer table 6, illustrating other variant spellings.
Note added in proof: Both authors found it hard to proofread an article intended to contain many variant spellings. We apologise if, inadvertently, we have sometimes spelt drug names correctly.
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